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Direct regulation of the pacemaker “funny” current (If) by cyclic AMP (cAMP) underlies 
heart rate modulation by the autonomic nervous system. At the molecular level, cAMP 
activates hyperpolarization-activated cyclic nucleotide-gated (HCN) channels that drive If 
in sinoatrial node (SAN) myocytes. Even though HCN channel genes were identified more 
than 20 years ago, the understanding of how cAMP regulates their gating is still fragmented. 
Here we summarize present understanding on how the cAMP signal is transmitted from 
the cytosolic to the transmembrane (TM) domain in HCN4. We further discuss how detailed 
structural knowledge prompted the development of pharmacological/genetic tools for 
the control of cAMP regulation in these channels.
Keywords: cyclic AMP, hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, regulation, structure, 
“funny” current, heart rate
INTRODUCTION
Automaticity of heartbeat originates in the sinoatrial node (SAN), where specialized cardiomyocytes 
initiate spontaneous impulses in the absence of external stimuli. A main player of cardiac 
automaticity is the “funny” current (If) that, unique among voltage-gated channels, is activated 
by hyperpolarization of membrane voltage. If is a mixed Na+/K+ inward current that slowly 
depolarizes pacemaker cells to the threshold for action potential firing (DiFrancesco, 1993). 
In addition to voltage, If is modulated by the second messenger cyclic AMP (cAMP), which 
enhances channel open probability, shifting the voltage-dependency of opening to more positive 
values and increasing the amount of current at any given voltage (DiFrancesco and Tortora, 
1991). This mechanism is of crucial physiological relevance as it contributes to the autonomic 
regulation of heart rate by adrenaline and acetylcholine, which modulate cAMP concentration 
of SAN myocytes. It is indeed worth noting that cAMP controls different pathways in SAN 
myocytes, all converging to the modulation of heart rate (Behar et  al., 2016).
The molecular determinants of If are hyperpolarization-activated cyclic nucleotide-gated 
(HCN) channels (Santoro et  al., 1998; Ludwig et  al., 1999; Wainger et  al., 2001). HCN channels 
are encoded by four distinct genes in mammals (HCN1–HCN4). The four closely related 
isoforms each express a hyperpolarization-activated cation current, whose kinetics range from 
fast (HCN1) to very slow (HCN4). HCN isoforms also differ in their voltage-dependence with 
HCN1 opening at the most depolarized and HCN4 at the most hyperpolarized potentials (as 
assessed by their half-activation voltage or V1/2 value). The channels further differ in their 
cAMP response with HCN1 displaying the smallest and HCN4 the largest maximal voltage 
shift with saturating concentrations of ligand (Wahl-Schott and Biel, 2009). HCN4 is the main 
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subunit expressed in SAN (Brioschi et  al., 2009), and the 
characteristic properties of HCN4, slow activation kinetics and 
the strong response to cAMP, closely match those of If (Baruscotti 
and Difrancesco, 2004). Noteworthy, HCN1 and HCN2 have 
been found in the SAN as well, but the levels of expression 
are usually much lower compared to HCN4 and vary a lot 
among different species. Despite their poor presence, there is 
evidence that they contribute to the cardiac pacemaking If 
(Herrmann et al., 2011; Bucchi et al., 2012; Fenske et al., 2013).
As for the role of HCN in heart rate acceleration during 
sympathetic stimulation, there are controversial reports on the 
role of HCN4. Two initial studies performed in mice deleted 
of HCN4  in a temporally controlled manner showed that the 
cAMP regulation of HCN4 is not required for the modulation 
of the heart rate, as the ECG recordings in freely moving 
HCN4 knockout (KO) mice did not reveal major alterations 
of the cardiac electrical activity (Herrmann et  al., 2007; Hoesl 
et  al., 2008). However, further studies highlighted the essential 
role of HCN4  in establishing the basal heart rate and its 
cAMP-dependent regulation and in reaching the maximal heart 
rate (Alig et  al., 2009; Baruscotti et  al., 2011). Therefore, the 
relevance of HCN4 for the regulation of heart rate is clear, 
though HCN4 may not contribute to all the phenomena involved 
in this process. The role of HCN4  in the different levels of 
modulation of heart rate has been already analyzed in detail 
in a review (Bucchi et  al., 2012) and it is beyond the purpose 
of our review, which, as already stated, is specifically focused 
on the molecular details of cAMP regulation of HCN4.
Here, we  review current knowledge on how cAMP binds 
to HCN channels and affects their gating mechanism. Taking 
HCN4 as a paradigm, we  will further show how the precise 
knowledge of this mechanism leads to the discovery of modalities 
to interfere with it, paving the way to future therapeutic and 
pharmacological interventions for the control of heart rate.
INSIGHT INTO cAMP REGULATION 
COMES FROM THE STRUCTURES OF 
HCN CHANNELS
To date, the available structural information on HCN channels 
include the full length model of HCN1 (Lee and MacKinnon, 
2017, 2019) and several detailed structures of the cytosolic 
domain, which host the cAMP binding sites of HCN4, HCN2, 
and HCN1 (Zagotta et  al., 2003; Xu et  al., 2010; Lolicato 
et  al., 2011, 2014; Akimoto et  al., 2014; Saponaro et  al., 2014).
The full length structure of the human HCN1 channels 
was recently solved using cryo-electron microscopy single 
particle analysis (cryo-EM) in the presence and absence of 
bound cAMP (Lee and MacKinnon, 2017, 2019). The overall 
structure of HCN channels is similar to that of other members 
[EAG (Whicher and MacKinnon, 2016) and hERG (Wang and 
MacKinnon, 2017)] of the superfamily of voltage-gated K+ 
channel to which HCN belongs.
HCN channels are composed of four subunits assembled around 
a central pore. Figure  1A displays only two opposite subunits 
in the membrane and four in the cytosolic side, for clarity. 
Each monomer is composed of six transmembrane (TM) domains, 
of which S1–S4 form the voltage sensor domain (VSD) and 
S5–S6 form the pore domain (PD) that hosts the selectivity 
filter (SF). The N and C termini are cytosolic, the N-terminus 
contains the HCN domain (HCND) and the C terminus contains 
the cyclic nucleotide binding domain (CNBD), which is connected 
to the S6  in the PD via a C-linker. The C-linker contains 
two helix-turn-helix motifs (formed by helices A', B' and 
C', D', respectively) that form the gating ring of the tetramer 
by resting as “an elbow on the shoulder” of the neighbor 
subunit (Zagotta et  al., 2003).
Binding of cAMP occurs at the CNBD and initiates the 
signal that is transmitted via the C-linker to the TM part of 
the channel, where it increases pore open probability by reducing 
the energetic request of the VSD. Figure 1B shows the response 
of HCN4 currents to the addition of saturating concentrations 
(30  μM) of cytosolic cAMP. Ligand binding increases the 
amount of current recorded at intermediate voltage (−90  mV 
in this example) without affecting the maximal current recorded 
at saturating voltage (−135  mV). This effect of the ligand on 
voltage-dependency of the channel is reflected in a right shift 
(about 20  mV) of the half activating voltage (V1/2), as shown 
in the activation curve that describes channel open probability 
as a function of voltage (Figure  1C).
The comparison of the available HCN1 structures, obtained 
in the cAMP-free (apo) and -bound (holo) form, provides little 
mechanistic information on how pore gating may be modulated 
by cAMP. Minimal differences in the conformation of the C-linker 
are observed between the apo and holo structures of HCN1 
(Lee and Mackinnon, 2017), despite a large body of literature 
arguing that movements of the CNBD transfer force to the 
TMD portion of the channel through a rearrangement in the 
C-linker, leading to a rotation of the elbow (Craven and Zagotta, 
2004; Craven et  al., 2008; Weissgraeber et  al., 2017; Gross et  al., 
2018). This finding is somehow not surprising considering the 
known minimal response of HCN1 to cAMP (Porro et al., 2019), 
and highlights the expectation for other structures of HCN 
isoforms with a larger cAMP response to come.
Present knowledge on the intramolecular pathway of cAMP 
effect in HCN channels, thus relies on a large amount of previous 
work performed on the isolated cytosolic portion of the channel 
that comprises only the CNBD or the C-linker/CNBD (Zagotta 
et  al., 2003; Xu et  al., 2010; Lolicato et  al., 2011, 2014; Puljung 
and Zagotta, 2013; Akimoto et  al., 2014; Puljung et  al., 2014; 
Saponaro et  al., 2014). It is nonetheless to be  mentioned that, 
despite the above numerous studies showing that the cAMP 
modulation in HCN is mediated by direct binding of the 
molecule to the CNBD, it has been reported that the channel 
can be also regulated by a cAMP-dependent mechanism through 
protein kinase A (PKA; Liao et  al., 2010).
THE CONFORMATIONAL CHANGES 
INDUCED BY cAMP IN THE CNBD
The CNBD has the conserved motif of a per-ARNT-sim 
(PAS) domain composed by a beta roll (beta sheets 1–7) 
Porro et al. cAMP Regulation of HCN4
Frontiers in Physiology | www.frontiersin.org 3 July 2020 | Volume 11 | Article 771
and alpha helices (E', F', A, B, P, and C). It contains a 
cAMP binding pocket at the interface between the beta roll 
and the alpha helices. Binding of cAMP induces most changes 
in the C-helix. The C-helix undergoes a translational movement 
toward the beta roll and establishes crucial contacts with 
the cAMP moiety. During this process the C-terminal end 
of the C-helix folds and the overall length of the helix 
increases, thus becoming a sort of a “lid” on the binding 
pocket. The other relevant movement occurring in the CNBD 
upon cAMP binding is the upward displacement of helices 
E' and F' (Saponaro et  al., 2014). These two helices are 
directly connected to the C-linker. Their movement thus 
transmits the cAMP signal to the C-linker, initiating the 
conformational changes that will eventually affect pore opening. 
It is therefore expected that blocking cAMP-induced movements 
in the CNBD will prevent the effect of the ligand on the 
current. Indeed, in the nervous system, HCN channels have 
a cytosolic regulatory subunit, TRIP8b, that inhibits channel 
response to cAMP by physically interacting with the CNBD 
(Santoro et al., 2004; Hu et al., 2013; Saponaro et al., 2014, 2018). 
The minimal portion of TRIP8b that recapitulates the effect 
of the full length protein on channel gating is 40 residues 
long (named TRIP8bnano) and comprises two short alpha 
helices, which fold upon binding to the CNBD (Saponaro 
et  al., 2018). The structural model of the complex between 
HCN2 CNBD and TRIP8bnano was obtained by NMR, and 
is shown in Figure  2B. TRIP8bnano (in green) binds to the 
CNBD in the cAMP-unbound (apo) state (in gray) and its 
interaction is predominately driven by electrostatic contacts 
with the CNBD C-helix.
The structural model of the complex fully explains the 
articulated mechanism through which TRIP8b antagonizes 
cAMP binding to the CNBD. cAMP and TRIP8b share the 
same binding sites on the C-helix and this accounts for the 
direct competition previously highlighted by functional studies 
(Han et  al., 2011; Deberg et  al., 2015; Bankston et  al., 2017). 
On the other hand, TRIP8b interacts with the loop between 
E'-F' helices (N-bundle loop, colored in yellow in Figure  2B), 
which constitutes an allosteric regulative element for cAMP 
binding (Saponaro et al., 2018). This accounts for the allosteric 
inhibition component of the antagonistic action of TRIP8b on 
the cAMP effect previously proposed (Hu et  al., 2013).
A
B C
FIGURE 1 | (A) Left, ribbon representation (side view) of two opposite subunits of HCN1 (PDB_ID: 5U6O) colored in blue and light blue. The four cytoplasmic 
C-terminal regions of HCN1 are shown and colored in blue, brown, light blue, and yellow. Right, ribbon representation (side view) of one subunit of HCN1. The 
domains of the protein are labeled: The Cytoplasmic N-terminal hyperpolarization-activated cyclic nucleotide-gated domain (HCND) in orange, the voltage 
sensor domain (VSD) in magenta, the pore domain (PD) in green, the cytoplasmic C-terminal C-linker in light blue, and the cyclic nucleotide binding domain 
(CNBD) in red. (B) Representative whole-cell currents of HCN4 recorded at the indicated voltages in control solution (left) and in the presence of saturating cyclic 
AMP [cAMP; right; adapted from Porro et al. (2019) with permission]. Scale bar is 200 pA × 500 ms. (C) Mean activation curves of HCN4 in control solution 
(black) and in the presence of saturating cAMP [red; adapted from Porro et al. (2019) with permission]. Values of the activation curves are shown as 
mean ± SEM.
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Thus, even though cAMP can still bind to the pocket inside 
the beta roll, the presence of TRIP8bnano prevents cAMP-
induced movements in the C-helix and in the E'-F' helices 
(shown in Figure  2A), thus inhibiting cAMP effect on the 
current (Figure  2C).
TRIP8bnano has been used as a peptide tool to selectively 
prevent adrenergic regulation of If in SAN myocytes, reducing 
the action potential firing rate in isolated myocytes by 
about 30% (Saponaro et  al., 2018). TRIP8bnano is also 
available in a cell-penetrating form, obtained by fusing the 
viral TAT peptide sequence at its N-terminus (Saponaro et al., 
2018). In this form, TRIP8bnano can be  added directly to the 
external solution, widening its range of applications as a 
research tool as well as a potential peptide drug whenever 
the response of HCN channels to cAMP needs to 
be  dampened.
A B C
D E F
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FIGURE 2 | (A) Superimposition of the two structures of HCN2 CNBD, represented as ribbons, solved in the absence (gray, PDB_ID: 2MPF) and in the 
presence of cAMP (red, PDB_ID: 3U10). cAMP, represented as red sticks, is shown within the beta roll. The structural elements involved in the principal 
movements induced by cAMP are labeled. The black arrows indicate the direction of such movements. (B) Ribbon representation of HCN2 CNBD (gray) in 
complex with TRIP8bnano peptide [green; adapted from Saponaro et al. (2018) with permission]. The structural elements of both proteins are labeled. The 
N-bundle loop of the CNBD is colored in yellow. The crucial residues involved in the interaction are shown as sticks and labeled. In particular, the negative 
residues of TRIP8bnano are colored in red, while in blue the positive residues of HCN2 CNBD. (C) Mean activation curves of HCN4 in control solution (black), in 
the presence of cAMP (red) and in the presence of cAMP and TRIP8bnano [blue; adapted from Saponaro et al. (2018) with permission]. (D) Ribbon representation 
of HCN4 C-linker/CNBD (green) solved in the presence of cGMP (PDB_ID: 4KL1). The two cyclic GMP (cGMP) molecules, represented as sticks, are shown and 
colored in yellow. (E) Docking simulation of c-di-GMP (magenta stick) molecule in the structure of HCN4 C-linker/CNBD (green) solved in the presence of cGMP 
[PDB_ID: 4KL1; adapted from Lolicato et al. (2014) with permission]. The crucial residues involved in the interaction with c-di-GMP are shown, labeled and 
colored based on their chemical nature: blue and red for the positively and negatively charged residues, respectively. The cGMP molecule bound to CNBD is 
represented as sticks and colored in yellow. (F) Mean activation curves of HCN4 in control solution (black), in the presence of cAMP (red) and in the presence of 
cAMP and c-di-GMP [blue; adapted from Lolicato et al. (2014) with permission]. (G) Ribbon representation (side view) of two opposite subunits of HCN1 (gray, 
PDB_ID: 5U6O). The HCNDs are colored in orange, the VSDs are colored in magenta, and the C-linker “elbow” elements (A' and B' helices) are colored in blue 
and light blue in the two subunits. (H) Top view of the HCNDs (orange) and the C-linker “elbow” elements (one subunit in blue and the other three in light blue). 
The structural elements forming the HCND and the C-linker “elbow” elements are labeled. The residues involved in the interaction between the HCND and two 
adjacent C-linker “elbows” are shown as sticks, labeled and colored-coded based on their chemical nature as in panels (B,E). (I) Mean activation curves of 
HCN4 wt (black) and K543A-E557A double mutant [blue; adapted from Porro et al. (2019) with permission]. Values of the activation curves shown in panels 
(C,F,I) are shown as mean ± SEM.
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TRANSMISSION OF cAMP EFFECT 
THROUGH THE C-LINKER
X-ray crystallography has been successfully used to obtain 
the structure of the cytosolic portion of HCN channels that 
include the C-linker and the CNBD (C-linker/CNBD; 
Zagotta et  al., 2003; Xu et  al., 2010; Lolicato et  al., 2011, 
2014). In these structures, the C-linker adopts a tetrameric 
configuration known as “elbow on shoulder,” in which the 
elbow of one subunit, formed by helices A' and B', rests on 
the shoulder, formed by helices C' and D' of the adjacent 
subunit. Such a configuration has been confirmed by the full 
length structure of HCN1 (Lee and MacKinnon, 2017, 2019). 
Several hydrophilic and hydrophobic contacts connect the 
elbow and the shoulder creating a network of interactions 
that can easily propagate the CNBD-initiated movements 
toward the TM domains. In the specific case of HCN4, in 
which the C-linker/CNBD was crystallized in the presence 
of the agonist cyclic GMP (cGMP), the ligand was found to 
be  bound to a second pocket, besides the canonical ligand 
binding site in the CNBD (Lolicato et  al., 2014). This result 
led to the discovery of a regulatory pocket at the interface 
between the CNBD and the C-linker, the C-linker pocket 
(CLP; Figure  2D). In silico docking performed in the CLP, 
identified a class of potential binders, cyclic-di-nucleotides 
(c-di-nucleotide; Figure  2E). This is a class of regulatory 
molecules originally discovered in bacteria (c-di-GMP and 
c-di-AMP) but more recently found also in mammals (cGAMP; 
Wu et  al., 2013). When tested in patch clamp experiments, 
c-di-GMP, c-di-AMP, and cGAMP, all efficiently prevented 
cAMP effect in HCN4 channels with micromolar (c-diGMP 
and c-di-AMP) and submicromolar (cGAMP) affinity (Lolicato 
et al., 2014). Several mutations introduced in the CLP, prevented 
c-di-nucleotide action allowing normal cAMP response of 
the mutants channels (Figure  2F; Lolicato et  al., 2014). It is 
believed that the occupancy of the CLP by c-di-nucleotides 
blocks the transmission of the movement from the CNBD 
to the C-linker inasmuch as the CLP corresponds to the 
flexible link between the two movable parts of the C-linker, 
the elbow and the shoulder. In this way, the upward movement 
of the E' and F' helices of the CNBD (see Figure  2A) cannot 
be  converted into the expected rotation of the upper part 
of the C-linker.
Notably, this effect is isoform-specific as only HCN4 responds 
to c-di-nucleotides (Lolicato et  al., 2014). This is remarkable, 
given the high degree of amino acid conservation in the critical 
residues of the CLP among different HCN subunits. At the 
same time, this is very exciting because c-di-nucleotides constitute 
the only HCN-specific inhibitors available so far. C-di-nucleotides 
have been shown to reduce cAMP response and firing rate in 
isolated myocytes of the SAN of mouse (Lolicato et  al., 2014). 
It is worth noting that, even though there is no direct evidence 
of c-di-nucleotides in the heart, it is known that the key enzyme 
for cGAMP production, cyclic-GMP-AMP synthase (cGAS), is 
highly expressed in human cardiac tissues (Uhlen et  al., 2010). 
Moreover, it was demonstrated that c-di-nucleotides can be also 
transferred from producing cells to neighboring cells through 
gap junctions, thus rapidly spreading them in a horizontal 
manner (Ablasser et al., 2013). So far, c-dinucleotides as second 
messengers in mammals have been associated to the immune 
system (Li et  al., 2013), but the findings reported above allow 
to hypothesize a possible role of endogenous c-di-nucleotides 
in the control of If, either because of their direct production 
in cardiomyocytes, or because of their spreading via gap junctions 
following the activation of the immune response.
THE TRANSMISSION OF THE cAMP 
EFFECT TO THE TM DOMAIN
The full length structure of HCN1 has shown for the first 
time in the presence of three helical folded domains (helices 
A–C, see Figures  2G,H), termed HCND, at the cytosolic 
N-terminus of the channel, right before TM1 (Lee and 
MacKinnon, 2017). In the 3D structure, the HCND wedges 
in between the C-linker and the VSD possibly establishing 
contacts with both of them (Figure  2G). In a recent work, 
Porro et  al. (2019) highlighted the network of hydrophobic 
and hydrophilic interactions that physically connect the HCND 
to the C-linker and the VSD, and underscored their crucial 
role in mechanically transmitting the cAMP effect from the 
cytosolic to the TM domain (Porro et  al., 2019). Figure  2H 
shows a top view of the tetrameric arrangement of the HCND 
and the C-linker. Each HCND, in orange, establishes, via the 
top part, hydrophobic contacts with the VSD, in magenta, of 
its own subunit in the membrane (not shown) and with the 
lower part electrostatic interactions with the C-linkers of the 
adjacent (light blue) and opposite (blue) subunits. The HCND 
thus forms a physical continuum between the cytosolic C-linker 
and the TM VSD domain.
Mutations of the two resides on the C-linker, E436 and 
K422 (human HCN1 numbering), completely abolish the response 
of the channel to cAMP, leaving the properties of the channel 
unaltered. This result was reproduced in all HCN isoforms 
tested, HCN1, HCN2, and HCN4 (Figure  2I shows the effect 
of the double mutation in HCN4; Porro et al., 2019), confirming 
the hypothesis that the HCND is involved in the transmission 
of the cAMP-induced movement from the cytosolic to the 
TM domain. In particular, on the basis of molecular dynamic 
(MD) simulations and linear response theory calculations, it 
was concluded that the HCND acts as a transmission crank 
converting the circular rotation of the C-linker into a vertical 
displacement in the VSD (Porro et  al., 2019).
These data provide structural-based support to the view 
that the C-linker must be  physically connected to the VSD 
to transmit cAMP-induced movements originating in the 
CNBD. Experimental evidences came originally from a study 
of Kusch et  al. (2010) showing that, in HCN2, the movement 
of the voltage sensor changes the affinity for cAMP in the 
CNBD without involving the PD. This result was obtained 
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by simultaneous recording of currents and fluo-cAMP 
binding, a technique that goes under the name of patch-
clamp fluorometry.
Even though the precise allosteric pathway is not yet defined 
in full detail, it is nonetheless expected that this communication 
pathway works in both directions, and that the signal of the 
presence of cAMP and the signal of the presence of voltage 
will travel along the same pathway through the HCN tetramer, 
although in opposite directions.
In conclusion, recent advancement in the comprehension 
of how cAMP regulates gating in HCN channels came from 
structural studies of the full length as well as from cytosolic 
portions of the channel. Reconstruction of the allosteric pathway 
from the CNBD to the VSD allows the control and the command 
over cAMP effect in the channel providing new tools for 
research and future pharmacological intervention.
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